CureVac, once a player in the Covid-19 vaccine race, announced that it plans to reduce costs across the company.
GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave's next generation...
GSK reveals data on novel gonorrhoea drug gepotidacin
April 17 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above, six to 11 years after vaccination.
Compared with approved products, the multivalent mRNA vaccine generated superior antibody titers against influenza A strains, but not against B strains.
U.S. FDA approves Akebia`s anemia drug
The CEOs of AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Novartis, Pfizer and Takeda came together in Beijing to show the companies’ continued interest in China and to offer their advice for the country’s healthcare industry.
After GSK’s $2 billion buyout of Canada-based Bellus Health last summer, an undisclosed number of the biotech’s team members are out of a job.